Y-Intercept (HK)’s P3 Health Partners PIII Stock Holding History

Y-Intercept (HK)’s Portfolio PIII Stock Details PIII Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-3,952	Closed	-$89K	–	1688
2024 Q2	$89K	Buy	+3,952	New	+$118K	﹤0.01%	1270

Other funds holding PIII

Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return

Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Corient Private Wealth Miami, Florida $69.9B AUM 22.19% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

AWC

Abundance Wealth Counselors State College, Pennsylvania $1.54B AUM 31.07% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Y-Intercept (HK)'s PIII Position: Q3 2024 in Review

Y-Intercept (HK) sold out of P3 Health Partners (PIII) in Q3 2024, closing a stake of 3,952 shares — an estimated $89K sold.

Y-Intercept (HK) first reported a position in PIII in Q2 2024 and held it in 1 quarter. The position peaked at $89K in Q2 2024. 46 funds tracked by Wall St. Rank hold PIII as of Q3 2024.

Y-Intercept (HK) reported no remaining P3 Health Partners position as of Q3 2024 after selling out during the quarter.
Y-Intercept (HK) sold 3,952 P3 Health Partners shares in Q3 2024, an estimated $89K.
Y-Intercept (HK) first reported a position in P3 Health Partners in Q2 2024 and held it in 1 quarter.
Y-Intercept (HK)'s P3 Health Partners position peaked at $89K in Q2 2024.
46 funds tracked by Wall St. Rank held P3 Health Partners as of Q3 2024.

Based on Y-Intercept (HK)'s 13F filing for Q3 2024, filed 15 Nov 2024.